Nordic Bioscience at the 6th DDDS
Nordic Bioscience is traveling to Boston, MA, to discuss the latest findings in inflammatory skin diseases. Among others, we'll discuss the utility of collagen turnover biomarkers in psoriasis, hidradenitis suppurutiva, and multiple sclerosis.
"The 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases returns to Boston this fall. Amidst the immense range and a steady stream of the novel, topical, and systemic agents entering exciting early phases, now is the time to gain insight from other leaders in the space.
As the world’s leading and only forum committed to overcoming significant R&D hurdles and sharing best practices for advancing efficacious next-generation therapies for chronic inflammatory skin conditions, can you really afford to miss out?
With the rising demand for patient-specific and alternative treatment options, along with some first-in-class treatments in the likes of Alopecia Areata – the 6th annual meeting addresses genetic discoveries, antibody drug development, delivery strategies, and predictive and diagnostic technologies when developing safe and effective drugs for moderate-to-severe, inflammatory skin conditions." (6th Dermatology Drug Development Summit
We hope to see you there!
